{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05712447",
            "orgStudyIdInfo": {
                "id": "CAS-CAS005-01"
            },
            "organization": {
                "fullName": "The Emmes Company, LLC",
                "class": "INDUSTRY"
            },
            "briefTitle": "Duchenne Muscular Dystrophy Video Assessment Registry",
            "officialTitle": "Duchenne Muscular Dystrophy Video Assessment Registry",
            "acronym": "ARISE",
            "therapeuticArea": [
                "Other"
            ],
            "study": "duchenne-muscular-dystrophy-video-assessment-registry"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-12",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-09-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-09-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-09-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-11-30",
            "studyFirstSubmitQcDate": "2023-02-01",
            "studyFirstPostDateStruct": {
                "date": "2023-02-03",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-12-12",
            "lastUpdatePostDateStruct": {
                "date": "2023-12-18",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "The Emmes Company, LLC",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Department of Defense Duchenne Muscular Dystrophy Research Program",
                    "class": "UNKNOWN"
                },
                {
                    "name": "Parent Project Muscular Dystrophy",
                    "class": "OTHER"
                },
                {
                    "name": "Ultragenyx Pharmaceutical Inc",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "ARISE is a prospective and longitudinal clinical study of individuals with Duchenne Muscular Dystrophy (DMD) aimed at creating a database of functional motor abilities in this population to support validation efforts of the Duchenne Video Assessment (DVA).",
            "detailedDescription": "ARISE is a longitudinal, observational study of individuals with Duchenne muscular dystrophy (DMD). The Duchenne Video Assessment (DVA) is a home-based clinical outcome assessment that measures ease of movement through identification of compensatory movement patterns. The DVA directs caregivers to video record patients doing specific movement activities at home using a secure mobile application. In this study, participants will remotely complete the DVA in addition to existing DMD functional assessments (North Star Ambulatory Assessment (NSAA) and Performance of Upper Limb (PUL 2.0)) to evaluate the longitudinal measurement properties of the DVA."
        },
        "conditionsModule": {
            "conditions": [
                "Duchenne Muscular Dystrophy"
            ],
            "keywords": [
                "Duchenne",
                "DMD",
                "Remote video assessment"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 180,
                "type": "ESTIMATED"
            }
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Duchenne Video Assessment (DVA)",
                    "description": "The DVA is a home-based clinical outcome assessment that measures ease of movement through identification of compensatory movement patterns. The DVA includes 18 standardized movement tasks that are assigned to participants based on functional subgroup. The DVA directs and trains caregivers to video record patients doing specific movement tasks at home using a secure mobile application. DVA videos are scored by DVA-certified physical therapists using validated scorecards with prespecified compensatory movement criteria.",
                    "timeFrame": "24 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "North Star Ambulatory Assessment (NSAA)",
                    "description": "The NSAA is a 17-item tool used to measure functional motor abilities in ambulatory individuals with DMD. Physical therapists with experience administering the NSAA will remotely administer and record the live NSAA sessions via a secure video conference platform. Participants will receive the appropriate standardized testing equipment.",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "Performance of Upper Limb 2.0 (PUL 2.0)",
                    "description": "The PUL 2.0 is a 22-item rating scale used to measure upper limb abilities in individuals with DMD. The test includes an entry test item to define starting functional level and 21 test items subdivided into shoulder level, elbow level, and distal level. Physical therapists with experience administering the PUL 2.0 will remotely administer and record the live PUL 2.0 sessions via secure video conference platform. Participants will receive the appropriate standardized testing equipment.",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "Caregiver Task-Specific Impression of Change",
                    "description": "At each follow-up assessment timepoint, parents/legal guardians or recording partners will complete an electronic questionnaire to rate their impression of change in the participant's ability to perform each DVA movement task since the prior timepoint.",
                    "timeFrame": "24 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* At least 2 years of age at time of consent\n* Written consent (English only) by adult participant or parent/legal guardian of minor participant\n* Written assent (English only) if minor participant is at least 7 years of age\n* Documentation provided for the participant's diagnosis of DMD (i.e., genetic report, clinic note)\n\nExclusion Criteria:\n\nParticipants will be excluded if they are unable to use a hand to hold a pen, pick up pennies or drive a powerchair.",
            "sex": "ALL",
            "minimumAge": "2 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Participants will be recruited for this study through referrals from collaborators and advocacy groups as well as through direct marketing via social media, email, phone, or other appropriate methods. Advocacy groups will assist with the facilitation of recruitment by making recruitment materials available to the Duchenne community. Participants who provided consent to be contacted by Casimir staff for future studies and shared their contact information with Casimir staff may be contacted. Potential participants may also share their contact information directly with Casimir study staff to learn about the study. Additionally, recruitment for the study may also occur through postings with patient advocacy groups and on social media. Casimir will supply the advocacy groups with language for website postings and group emails.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Katherine Pleasant",
                    "role": "CONTACT",
                    "phone": "774-433-9313",
                    "email": "kpleasant@emmes.com"
                },
                {
                    "name": "Mary Hubbard",
                    "role": "CONTACT",
                    "phone": "888-283-1635",
                    "email": "mhubbard@emmes.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Marielle Contesse, PhD",
                    "affiliation": "Emmes Endpoint Solutions",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Emmes",
                    "status": "RECRUITING",
                    "city": "Rockville",
                    "state": "Maryland",
                    "zip": "20850",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "888-283-1635",
                            "email": "ARISE@casimirtrials.com"
                        },
                        {
                            "name": "Mindy Leffler",
                            "role": "CONTACT",
                            "phone": "(425) 785-2934",
                            "email": "mleffler@emmes.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.084,
                        "lon": -77.15276
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009136",
                    "term": "Muscular Dystrophies"
                },
                {
                    "id": "D000020388",
                    "term": "Muscular Dystrophy, Duchenne"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020966",
                    "term": "Muscular Disorders, Atrophic"
                },
                {
                    "id": "D000009135",
                    "term": "Muscular Diseases"
                },
                {
                    "id": "D000009140",
                    "term": "Musculoskeletal Diseases"
                },
                {
                    "id": "D000009468",
                    "term": "Neuromuscular Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000040181",
                    "term": "Genetic Diseases, X-Linked"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12093",
                    "name": "Muscular Dystrophies",
                    "asFound": "Muscular Dystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22185",
                    "name": "Muscular Dystrophy, Duchenne",
                    "asFound": "Duchenne Muscular Dystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12092",
                    "name": "Muscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4589",
                    "name": "Atrophy",
                    "relevance": "LOW"
                },
                {
                    "id": "M22697",
                    "name": "Muscular Disorders, Atrophic",
                    "relevance": "LOW"
                },
                {
                    "id": "M12097",
                    "name": "Musculoskeletal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12411",
                    "name": "Neuromuscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M24877",
                    "name": "Genetic Diseases, X-Linked",
                    "relevance": "LOW"
                },
                {
                    "id": "T3963",
                    "name": "Muscular Dystrophy",
                    "asFound": "Muscular Dystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "T698",
                    "name": "Becker Muscular Dystrophy",
                    "asFound": "Duchenne Muscular Dystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1945",
                    "name": "Duchenne Muscular Dystrophy",
                    "asFound": "Duchenne Muscular Dystrophy",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC05",
                    "name": "Musculoskeletal Diseases"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}